Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 15.93B | 16.57B | 13.06B | 9.85B | 7.52B |
Gross Profit | 7.06B | 6.58B | 3.52B | 977.79M | 1.18B |
EBITDA | -3.69B | 3.23B | 1.44B | 1.23B | 538.84M |
Net Income | -5.38B | -280.18M | -2.68B | -3.05B | -2.54B |
Balance Sheet | |||||
Total Assets | 21.53B | 27.28B | 25.24B | 27.96B | 29.26B |
Cash, Cash Equivalents and Short-Term Investments | 10.81B | 10.92B | 11.88B | 15.24B | 16.66B |
Total Debt | 1.03B | 212.03M | 332.34M | 0.00 | 0.00 |
Total Liabilities | 11.48B | 4.67B | 3.18B | 2.57B | 1.94B |
Stockholders Equity | 10.05B | 22.62B | 22.06B | 25.38B | 27.31B |
Cash Flow | |||||
Free Cash Flow | -420.94M | -1.18B | -1.84B | -2.07B | -2.37B |
Operating Cash Flow | 1.13B | 2.24B | 953.69M | 641.94M | 880.74M |
Investing Cash Flow | -1.07B | -3.72B | -2.92B | -2.35B | -3.20B |
Financing Cash Flow | -50.88M | -27.14M | -1.32B | -36.95M | -20.42M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥28.00B | 12.35 | 2.74% | 1.65% | -2.94% | ||
77 Outperform | ¥34.53B | 24.06 | 0.66% | 17.26% | 20.28% | ||
75 Outperform | ¥26.41B | 13.53 | 4.28% | 13.54% | 15.43% | ||
73 Outperform | ¥26.31B | 34.51 | 1.62% | 5.38% | -8.86% | ||
67 Neutral | ¥34.80B | 15.48 | 2.86% | 21.47% | 30.65% | ||
61 Neutral | $36.05B | 6.66 | -10.10% | 1.86% | 8.68% | -8.81% | |
41 Neutral | ¥33.02B | 81.36 | ― | 11.98% | -168.68% |
ACCESS CO., LTD. reported a non-operating expense of 152 million yen due to foreign exchange losses and an extraordinary loss of 137 million yen related to restructuring efforts at its European subsidiary. These financial impacts have been accounted for in the company’s quarterly and annual financial forecasts, indicating a strategic move to enhance profitability and efficiency.
Access Co., Ltd. reported its consolidated financial results for the fiscal year ending January 31, 2025, showing a slight increase in net sales by 5.4% to ¥15,930 million. However, the company faced significant losses with an operating loss of ¥2,259 million and a net loss of ¥5,383 million, indicating challenges in profitability and financial stability. The financial outlook for the next fiscal year anticipates a substantial increase in net sales by 28.7% to ¥20,500 million, although the company still expects to incur losses. This reflects ongoing efforts to stabilize its financial position and improve operational efficiency, which could impact stakeholders and market positioning.
Access Co., Ltd. reported its consolidated financial results for the nine months ending October 31, 2024, showing a slight increase in net sales by 0.6% compared to the previous year. However, the company faced operating and ordinary losses, with a profit attributable to owners of the parent also in the negative. Despite these challenges, the capital adequacy ratio remains relatively strong at 64.6%, indicating a stable financial position. The company has not announced any dividends for the fiscal year ending January 31, 2025, reflecting a cautious approach amid financial uncertainties.
ACCESS CO., LTD. has announced details for the adjourned meeting of its 41st Ordinary General Meeting of Shareholders, initially held on April 30, 2025. The adjourned meeting is scheduled for July 29, 2025, to report on the financial results for the company’s 41st fiscal year. This meeting will include reports on both consolidated and non-consolidated financial statements, with the same shareholders eligible to attend as those at the original meeting.
ACCESS CO., LTD. announced a delay in the disclosure of its financial results for the fiscal year ended January 31, 2025, due to an investigation into improper sales recognition and accounting treatment issues at its U.S. subsidiary. The company has taken steps to correct past financial statements and is committed to improving its disclosure processes to prevent future delays, aiming to release financial results within 45 days after the fiscal year ends.
ACCESS CO., LTD. announced an extraordinary loss for the fiscal year ending January 2025, primarily due to special investigation fees and valuation losses on shares and investments in its subsidiaries. The company’s consolidated financial results showed a slight increase in net sales, but operating profit declined due to higher product development costs in the Network business. The extraordinary loss significantly impacted the profit attributable to owners of the parent, resulting in a greater net loss compared to the previous year.
Access Co., Ltd. has announced the implementation of measures to prevent the recurrence of inappropriate accounting practices identified in its U.S. subsidiary. The company plans to overhaul the management structure, strengthen administrative frameworks, and reform internal rules related to revenue recognition and software asset recognition. These steps are intended to enhance compliance and financial reporting integrity, reflecting a commitment to addressing past issues and improving oversight.
Access Co., Ltd. announced material weaknesses in its internal control over financial reporting due to improper sales recognition and asset valuation at its U.S. subsidiary, IP Infusion Inc. The investigation revealed overstated sales and software assets, leading to amended financial reports for previous fiscal years. The company identified inadequacies in internal controls and management involvement as key issues, impacting its financial reporting reliability and necessitating corrective measures.
Access Co., Ltd. has submitted amended internal control reports for fiscal years 2021 to 2024 due to significant inadequacies in financial reporting, particularly involving its U.S. subsidiary, IP Infusion Inc. The amendments were necessitated by improper sales recognition and overstatement of software assets, which were discovered through an investigation revealing management involvement in these discrepancies. This development highlights critical internal control weaknesses that could impact financial stability and stakeholder trust.
ACCESS CO., LTD. has successfully submitted its annual securities report for the fiscal year ended January 2025, following an approved extension. The company also released its financial results for the third quarter and full fiscal year, addressing previous delays and extending apologies to stakeholders for any inconvenience caused.
ACCESS CO., LTD. has announced the submission of correction reports for its annual, quarterly, and semi-annual financial documents due to improper sales recognition and accounting treatment issues discovered at its U.S. subsidiary. These corrections have led to the realization that past dividends exceeded the distributable amount, prompting the company to apologize to stakeholders and initiate a comprehensive investigation to rectify the discrepancies.
Access Co., Ltd. announced the receipt of an investigation report from a Special Investigation Committee regarding improper sales recognition and accounting practices at its U.S. subsidiary, IP Infusion Inc. The investigation revealed issues such as premature sales recognition and overstatement of software assets, necessitating corrections to past financial statements. These findings may impact the company’s financial performance and require adjustments to previously reported figures, potentially affecting stakeholders’ trust and the company’s market position.
ACCESS CO., LTD. has announced a delay in the release of its financial results for the first quarter of the fiscal year ending January 2026, due to ongoing investigations into improper sales recognition at its U.S. subsidiary. The company has established a special investigation committee to address these issues and aims to submit its annual securities report by the extended deadline, with the new date for the financial results announcement to be confirmed later.